Skip to content

The use of platelet rich plasma in the treatment of acute burns

The application of platelet rich plasma in the treatment of deep dermal burns: a randomized, double blind, intra-patient controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14946762
Enrollment
52
Registered
2015-09-11
Start date
2010-06-03
Completion date
Unknown
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn wounds Skin and Connective Tissue Diseases Burn wounds

Interventions

In patients with burn wounds, one area is treated with excision of the burn and application of a split skin graft (standard care) and in a comparable area with burn wounds, autologous platelet rich pl

Sponsors

Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and older 2. Admitted at the Dutch burn centre in Beverwijk with a full thickness or deep dermal burn wounds with a surface area of at least 2% total body surface area (TBSA) who needed transplantation with a split skin graft

Exclusion criteria

Exclusion criteria: 1. Likely problems, in the judgment of the investigators, with maintaining follow-up 2. Insufficient comprehension of the Dutch language to understand a rehabilitation program and other treatment information in the judgment of the attending physician

Design outcomes

Primary

MeasureTime frame
Take rate (percentage of the graft that appeared to be vital and showed good adherence to the wound bed) and epithelialization rate (percentage of the wound closure by either skin graft or outgrowth from graft or wound edges) of the split skin grafts of area A and B at day 5-7 post surgery, as judged by experienced burn clinicians.

Secondary

MeasureTime frame
1. Pain and itch scores of area A and B after surgery until discharge measured using Visual Analogue Thermometer (VAT) score 2. Bacterial status of area A and B before surgery and twice weekly until discharge with swabs 3. Scar quality at 3, 6 and 12 months of area A and B measured by the POSAS scar assessment scales, Dermaspectrometer (scar color and pigmentation) and Cutometer (scar elasticity)

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026